Who owns Sage Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Sage Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Sage Therapeutics stock

Who bought or sold Sage Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
DekaBank Deutsche Girozentrale 22k $460k 0% Dec 2025
 View chart
Huntington National Bank 1.00 $9.000000 0% Dec 2025
 View chart

Who sold out of Sage Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
D. E. Shaw & Co Jun 2025 1.9M $18M
Balyasny Asset Management Jun 2025 1.5M $14M
Millennium Management Jun 2025 1.2M $11M
Toronto-Dominion Bank Jun 2025 1.1M $9.9M
Harvest Management Jun 2025 889k $8.1M
AQR Capital Management Jun 2025 861k $7.9M
CNH Partners Jun 2025 409k $3.7M
Eisler Capital Management Jun 2025 330k $3.0M
Two Sigma Investments Jun 2025 268k $2.4M
Citadel Advisors Jun 2025 202k $1.8M
Two Sigma Advisers Jun 2025 199k $1.8M
Cubist Systematic Strategies Jun 2025 192k $1.8M
Tudor Investment Corporation Jun 2025 108k $988k
Bridgeway Capital Management Jun 2025 95k $866k
TIG Advisors Jun 2025 83k $759k
Alliancebernstein Jun 2025 60k $546k
Ohio Pers Jun 2025 50k $454k
Point72 Asia Jun 2025 44k $404k
Wolverine Trading Jun 2025 37k $338k
XTX Topco Sep 2025 30k $0
Springbok Capital Management Jun 2025 12k $112k
Royal Bank of Canada Jun 2025 5.9k $44k
FMR Jun 2025 4.1k $38k
Advisor Group Holdings Sep 2025 4.0k $35k
IFP Advisors Sep 2025 445.00 $3.9k
FSA Wealth Management Jun 2025 35.00 $319.000500